LifeClean International AB (LCLEAN) AI Stock Analysis

• Market Cap: €60.03M
• Dividend Yield: N/A
• Average Volume (3M): 7.09M
• Price to Earnings (P/E): ―
• Beta (1Y): -0.21
• Revenue Growth: -3.09%
• EPS Growth: 29.52%
• Country: SE
• Employees: 31
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Household & Personal Products
• EPS (TTM): -0.03
• Shares Outstanding: 274,110,400
• 10 Day Avg. Volume: 3,074,007
• 30 Day Avg. Volume: 7,093,746
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: €0.55
• Price Target Upside: 149.53% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 45 Neutral
• Price Target: kr0.00 ▼(-100.00% Downside)

The overall stock score is primarily impacted by the company's poor financial performance, characterized by declining revenue, negative profitability, and high leverage. Technical analysis provides a slightly positive outlook due to some bullish momentum, but valuation remains a concern with a negative P/E ratio. The absence of earnings call data and corporate events limits additional insights.

LifeClean International AB Business Overview & Revenue Model

Company Description

LifeClean International AB (publ) researches, produces, markets, and sells disinfection products in Sweden. It has developed a patented spore, fungal, biofilm, bacterial, and virus-killing surface disinfection for equipment and surfaces, such as floors, walls, furniture, and general roof surfaces. The company was founded in 2012 and is based in Uddevalla, Sweden.

How the Company Makes Money

LifeClean International AB generates revenue primarily through the sale of its disinfection products. The company's key revenue streams include direct sales to healthcare facilities, industrial clients, and public institutions that require high-level sanitation solutions. Additionally, LifeClean may engage in partnerships or distribution agreements with other organizations to expand its market reach. Factors contributing to its earnings include the growing demand for effective disinfection solutions in response to heightened awareness of hygiene and infection control, as well as regulatory requirements for sanitation in various sectors. By leveraging its expertise in producing innovative and sustainable disinfection products, LifeClean maintains a competitive position in the market, which supports its financial performance.

LifeClean International AB Financial Statement Overview

Summary

LifeClean International AB is facing significant financial challenges, with declining revenue, negative profitability, high leverage, and negative cash flows. The company needs to address operational inefficiencies and improve its financial stability to enhance its financial health and investor confidence.

Income Statement

LifeClean International AB has experienced declining revenue with a negative growth rate of -107.5% TTM. The company is facing significant profitability challenges, as evidenced by negative margins across the board: gross profit margin at 47.83%, net profit margin at -71.11%, EBIT margin at -66.25%, and EBITDA margin at -50.77%. These figures indicate substantial operational inefficiencies and a lack of profitability.

Balance Sheet

The balance sheet shows a high debt-to-equity ratio of 1.48, indicating significant leverage and potential financial risk. The return on equity is deeply negative at -10.73%, reflecting poor profitability relative to shareholder equity. However, the equity ratio is 30.06%, suggesting a moderate level of equity financing relative to total assets.

Cash Flow

The cash flow statement reveals negative operating and free cash flows, with a free cash flow growth rate of -421.5% TTM. The operating cash flow to net income ratio is -1.19, indicating cash flow issues relative to net income. The free cash flow to net income ratio is slightly positive at 1.04, suggesting some alignment between cash flow and accounting profit, despite overall negative cash flow.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	59.44M	61.15M	52.50M	47.18M	53.36M	31.79M
Gross Profit	28.43M	26.82M	22.77M	19.52M	-30.81M	24.04M
EBITDA	-30.18M	-40.87M	-32.39M	-27.79M	-26.05M	395.00K
Net Income	-42.26M	-53.72M	-44.24M	-36.09M	-32.75M	-3.48M
Balance Sheet
Total Assets	72.93M	61.80M	68.61M	76.37M	82.59M	76.47M
Cash, Cash Equivalents and Short-Term Investments	23.23M	10.57M	8.29M	11.61M	8.85M	42.45M
Total Debt	32.37M	44.90M	47.84M	32.38M	18.54M	4.45M
Total Liabilities	51.01M	65.43M	67.29M	62.56M	32.70M	11.53M
Stockholders Equity	21.92M	-3.63M	1.31M	13.81M	49.89M	64.94M
Cash Flow
Free Cash Flow	-35.52M	-42.66M	-39.99M	-20.07M	-23.01M	-12.49M
Operating Cash Flow	-34.15M	-40.83M	-35.46M	-16.96M	-21.79M	-5.09M
Investing Cash Flow	-1.34M	-1.85M	-4.54M	-3.13M	-36.51M	-7.81M
Financing Cash Flow	55.31M	44.96M	36.67M	22.84M	24.68M	52.90M

LifeClean International AB Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.22
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:LCLEAN, the sentiment is Negative. The current price of 0.22 is below the 20-day moving average (MA) of 0.26, above the 50-day MA of 0.19, and below the 200-day MA of 0.46, indicating a neutral trend. The MACD of <0.01 indicates Positive momentum. The RSI at 46.67 is Neutral, neither overbought nor oversold. The STOCH value of 23.62 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:LCLEAN.

LifeClean International AB Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CLEM	68 Neutral	137.08M	18.66	0.00%	―	5.89%	10.59%
LCLEAN	45 Neutral	€60.03M	―	-598.14%	―	-3.09%	29.52%
POLYG	43 Neutral	326.55M	-20.10	-3.70%	1.57%	21.21%	94.88%
NICO	41 Neutral	40.10M	-4.22	-52.60%	―	122.18%	-11.42%
QLIFE	39 Underperform	40.08M	-0.73	3917.49%	―	131.58%	98.36%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%